What is the DNA repair defect underlying Fanconi anemia?

Current Opinion in Cell Biology

Volumn 37, Issue , 2015, Pages 49-60

  Duxin, Julien P ^a   Walter, Johannes C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACETALDEHYDE; ACROLEIN; ALDEHYDE; CHLORMETHINE; DEOXYRIBONUCLEOPROTEIN; DNA; DNA BASE; DNA BINDING PROTEIN; DNA DIRECTED DNA POLYMERASE EPSILON; DNA POLYMERASE REV1; DNA TOPOISOMERASE; FANCONI ANEMIA ASSOCIATED PROTEIN 100; FANCONI ANEMIA ASSOCIATED PROTEIN 20; FANCONI ANEMIA ASSOCIATED PROTEIN 24; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP I PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA GROUP M PROTEIN; FANCONI ANEMIA PROTEIN; FLAP ENDONUCLEASE; FORMALDEHYDE; HYDROXYUREA; NUCLEASE; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA PROTEIN COMPLEX; DNA REPAIR; DNA REPLICATION; EXCISION REPAIR; FANCONI ANEMIA; GENOMIC INSTABILITY; HISTONE DEMETHYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; REPLISOME; REVIEW; ANIMAL; GENETICS; METABOLISM;

ANIMALS; DNA; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; HUMANS;

EID: 84945311821     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2015.09.002     Document Type: Review

References (132)

1. Fanconi G: Familiäre infantile perniziosaartige Anämie (perniziöses Blutbild und Konstitution). 1927, [no volume].
2. Lobitz S, Velleuer E: Guido Fanconi (1892-1979): a jack of all trades. 2006.
3. Sasaki M.S., Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973, 33:1829-1836.
4. Auerbach A.D., Wolman S.R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 1976, 261:494-496.
5. Akkari Y.M., Bateman R.L., Reifsteck C.A., Olson S.B., Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol Cell Biol 2000, 20:8283-8289.
6. Räschle M., Knipscheer P., Enoiu M., Angelov T., Sun J., Griffith J.D., Ellenberger T.E., Schärer O.D., Walter J.C. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 2008, 134:969-980.
7. Rothfuss A., Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol 2004, 24:123-134.
8. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002, 100:2414-2420.
9. Nakanishi K., Cavallo F., Perrouault L., Giovannangeli C., Moynahan M.E., Barchi M., Brunet E., Jasin M. Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication. Nat Struct Mol Biol 2011, 18:500-503.
10. Williams H.L., Gottesman M.E., Gautier J. The differences between ICL repair during and outside of S phase. Trends Biochem Sci 2013, 38:386-393.
11. Clauson C., Schärer O.D., Niedernhofer L. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair. Cold Spring Harb Perspect Biol 2013, 5.
12. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Publishing Group 2007, 8:735-748.
13. Qiao F., Moss A., Kupfer G.M. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J Biol Chem 2001, 276:23391-23396.
14. Kim J.M., Kee Y., Gurtan A., D'Andrea A.D. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 2008, 111:5215-5222.
15. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001, 7:249-262.
16. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007, 129:289-301.
17. Ciccia A., Ling C., Coulthard R., Yan Z., Xue Y., Meetei A.R., Laghmani E.H., Joenje H., McDonald N., de Winter J.P., et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell 2007, 25:331-343.
18. Singh T.R., Saro D., Ali A.M., Zheng X-F., Du C-H., Killen M.W., Sachpatzidis A., Wahengbam K., Pierce A.J., Xiong Y., et al. MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol Cell 2010, 37:879-886.
19. Yan Z., Delannoy M., Ling C., Daee D., Osman F., Muniandy P.A., Shen X., Oostra A.B., Du H., Steltenpool J., et al. A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol Cell 2010, 37:865-878.
20. Deans A.J., West S.C. FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi anemia. Mol Cell 2009, 36:943-953.
21. Collis S.J., Ciccia A., Deans A.J., Horejsi Z., Martin J.S., Maslen S.L., Skehel J.M., Elledge S.J., West S.C., Boulton S.J. FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol Cell 2008, 32:313-324.
22. Huang M., Kim J.M., Shiotani B., Yang K., Zou L., D'Andrea A.D. The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response. Mol Cell 2010, 39:259-268.
23. Gari K., Décaillet C., Stasiak A.Z., Stasiak A., Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol Cell 2008, 29:141-148.
24. Gari K., Décaillet C., Delannoy M., Wu L., Constantinou A. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc Natl Acad Sci U S A 2008, 105:16107-16112.
25. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003, 35:165-170.
26. Huang Y., Leung J.W.C., Lowery M., Matsushita N., Wang Y., Shen X., Do Huong Takata M., Chen J., Li L. Modularized functions of the Fanconi anemia core complex. Cell Rep 2014, 7:1849-1857.
27. Ling C., Ishiai M., Ali A.M., Medhurst A.L., Neveling K., Kalb R., Yan Z., Xue Y., Oostra A.B., Auerbach A.D., et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J 2007, 26:2104-2114.
28. Medhurst A.L., Laghmani E.H., Steltenpool J., Ferrer M., Fontaine C., de Groot J., Rooimans M.A., Scheper R.J., Meetei A.R., Wang W., et al. Evidence for subcomplexes in the Fanconi anemia pathway. Blood 2006, 108:2072-2080.
29. Rajendra E., Oestergaard V.H., Langevin F., Wang M., Dornan G.L., Patel K.J., Passmore L.A. The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell 2014, 54:858-869.
30. Hira A., Yoshida K., Sato K., Okuno Y., Shiraishi Y., Chiba K., Tanaka H., Miyano S., Shimamoto A., Tahara H., et al. Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am J Hum Genet 2015, 96:1001-1007.
31. Rickman K.A., Lach F.P., Abhyankar A., Donovan F.X., Sanborn E.M., Kennedy J.A., Sougnez C., Gabriel S.B., Elemento O., Chandrasekharappa S.C., et al. Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of Fanconi anemia. Cell Rep 2015, 12:35-41.
32. Virts E.L., Jankowska A., MacKay C., Glaas M.F., Wiek C., Kelich S.L., Lottmann N., Kennedy F.M., Marchal C., Lehnert E., et al. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum Mol Genet 2015, 24:5093-5108.
33. Machida Y.J., Machida Y., Chen Y., Gurtan A.M., Kupfer G.M., D'Andrea A.D., Dutta A. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell 2006, 23:589-596.
34. Alpi A.F., Pace P.E., Babu M.M., Patel K.J. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell 2008, 32:767-777.
35. Bogliolo M., Schuster B., Stoepker C., Derkunt B., Su Y., Raams A., Trujillo J.P., Minguillón J., Ramírez M.J., Pujol R., et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genetics 2013, 92:800-806.
36. Kim Y., Lach F.P., Desetty R., Hanenberg H., Auerbach A.D., Smogorzewska A. Mutations of the SLX4 gene in Fanconi anemia. Nat Genet 2011, 43:142-146.
37. Stoepker C., Hain K., Schuster B., Hilhorst-Hofstee Y., Rooimans M.A., Steltenpool J., Oostra A.B., Eirich K., Korthof E.T., Nieuwint A.W.M., et al. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet 2011, 43:138-141.
38. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M., et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 2007, 39:162-164.
39. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002, 297:606-609.
40. Wang A.T., Kim T., Wagner J.E., Conti B.A., Lach F.P., Huang A.L., Molina H., Sanborn E.M., Zierhut H., Cornes B.K., et al. A dominant mutation in human RAD51 reveals its function in DNA interstrand crosslink repair independent of homologous recombination. Mol Cell 2015, 59:478-490.
41. Vaz F., Hanenberg H., Schuster B., Barker K., Wiek C., Erven V., Neveling K., Endt D., Kesterton I., Autore F., et al. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 2010, 42:406-409.
42. Sawyer S.L., Tian L., Kähkönen M., Schwartzentruber J., Kircher M., University of Washington Centre for Mendelian Genomics, FORGE Canada Consortium, Majewski J., Dyment D.A., Innes A.M., et al. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov 2015, 5:135-142.
43. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., Elghalbzouri-Maghrani E., Steltenpool J., Rooimans M.A., Pals G., et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet 2005, 37:934-935.
44. Levran O., Attwooll C., Henry R.T., Milton K.L., Neveling K., Rio P., Batish S.D., Kalb R., Velleuer E., Barral S., et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 2005, 37:931-933.
45. Litman R., Peng M., Jin Z., Zhang F., Zhang J., Powell S., Andreassen P.R., Cantor S.B. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 2005, 8:255-265.
46. Nijman S.M.B., Huang T.T., Dirac A.M.G., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell 2005, 17:331-339.
47. Cohn M.A., Kowal P., Yang K., Haas W., Huang T.T., Gygi S.P., D'Andrea A.D. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell 2007, 28:786-797.
48. Kratz K., Schöpf B., Kaden S., Sendoel A., Eberhard R., Lademann C., Cannavo E., Sartori A.A., Hengartner M.O., Jiricny J. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 2010, 142:77-88.
49. Liu T., Ghosal G., Yuan J., Chen J., Huang J. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science 2010, 329:693-696.
50. MacKay C., Déclais A-C., Lundin C., Agostinho A., Deans A.J., MacArtney T.J., Hofmann K., Gartner A., West S.C., Helleday T., et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 2010, 142:65-76.
51. Yoshikiyo K., Kratz K., Hirota K., Nishihara K., Takata M., Kurumizaka H., Horimoto S., Takeda S., Jiricny J. KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents. Proc Natl Acad Sci U S A 2010, 107:21553-21557.
52. Zhou W., Otto E.A., Cluckey A., Airik R., Hurd T.W., Chaki M., Diaz K., Lach F.P., Bennett G.R., Gee H.Y., et al. FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet 2012, 44:910-915.
53. Karanja K.K., Cox S.W., Duxin J.P., Stewart S.A., Campbell J.L. DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network. Cell Cycle 2012, 11:3983-3996.
54. Karanja K.K., Lee E.H., Hendrickson E.A., Campbell J.L. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells. Cell Cycle 2014, 13:1540-1550.
55. Thangavel S., Berti M., Levikova M., Pinto C., Gomathinayagam S., Vujanovic M., Zellweger R., Moore H., Lee E.H., Hendrickson E.A., et al. DNA2 drives processing and restart of reversed replication forks in human cells. J Cell Biol 2015, 208:545-562.
56. Hashimoto Y., Chaudhuri A.R., Lopes M., Costanzo V. Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat Struct Mol Biol 2010, 17:1305-1311.
57. Schlacher K., Christ N., Siaud N., Egashira A., Wu H., Jasin M. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 2011, 145:529-542.
58. Schlacher K., Wu H., Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 2012, 22:106-116.
59. Niedernhofer L.J., Lalai A.S., Hoeijmakers J.H.J. Fanconi anemia (cross)linked to DNA repair. Cell 2005, 123:1191-1198.
60. Fu Y.V., Yardimci H., Long D.T., Guainazzi A., Bermudez V.P., Hurwitz J., van Oijen A., Schärer O.D., Walter J.C., Ho247 T.V. Selective bypass of a lagging strand roadblock by the eukaryotic replicative DNA helicase. Cell 2011, 146:931-941.
61. Long D.T., Joukov V., Budzowska M., Walter J.C. BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork. Mol Cell 2014, 56:174-185.
62. Maric M., Maculins T., de Piccoli G., Labib K. Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replication. Science 2014, 346:1253596.
63. Moreno S.P., Bailey R., Campion N., Herron S., Gambus A. Polyubiquitylation drives replisome disassembly at the termination of DNA replication. Science 2014, 346:477-481.
64. Budzowska M., Graham T.G., Sobeck A., Waga S., Walter J.C. Regulation of the Rev1-pol complex during bypass of a DNA interstrand cross-link. EMBO J 2015, 34:1971-1985.
65. Knipscheer P., Raschle M., Smogorzewska A., Enoiu M., Ho T.V., Scharer O.D., Elledge S.J., Walter J.C. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 2009, 326:1698-1701.
66. Yamamoto K.N., Kobayashi S., Tsuda M., Kurumizaka H., Takata M., Kono K., Jiricny J., Takeda S., Hirota K. Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway. Proc Natl Acad Sci U S A 2011, 108:6492-6496.
67. Klein Douwel D., Boonen R.A.C.M., Long D.T., Szypowska A.A., Räschle M., Walter J.C., Knipscheer P. XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol Cell 2014, 54:460-471.
68. Hodskinson M.R.G., Silhan J., Crossan G.P., Garaycoechea J.I., Mukherjee S., Johnson C.M., Schärer O.D., Patel K.J. Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair. Mol Cell 2014, 54:472-484.
69. Andersen S.L., Bergstralh D.T., Kohl K.P., LaRocque J.R., Moore C.B., Sekelsky J. Drosophila MUS312 and the vertebrate ortholog BTBD12 interact with DNA structure-specific endonucleases in DNA repair and recombination. Mol Cell 2009, 35:128-135.
70. Fekairi S., Scaglione S., Chahwan C., Taylor E.R., Tissier A., Coulon S., Dong M-Q., Ruse C., Yates J.R., Russell P., et al. Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell 2009, 138:78-89.
71. Muñoz I.M., Hain K., Déclais A-C., Gardiner M., Toh G.W., Sanchez-Pulido L., Heuckmann J.M., Toth R., Macartney T., Eppink B., et al. Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell 2009, 35:116-127.
72. Svendsen J.M., Smogorzewska A., Sowa M.E., O'Connell B.C., Gygi S.P., Elledge S.J., Harper J.W. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 2009, 138:63-77.
73. Wang H., Li Y., Truong L.N., Shi L.Z., Hwang P.Y-H., He J., Do J., Cho M.J., Li H., Negrete A., et al. CtIP maintains stability at common fragile sites and inverted repeats by end resection-independent endonuclease activity. Mol Cell 2014, 56:1012-1021.
74. Makharashvili N., Tubbs A.T., Yang S-H., Wang H., Barton O., Zhou Y., Deshpande R.A., Lee J-H., Lobrich M., Sleckman B.P., et al. Catalytic and noncatalytic roles of the CtIP endonuclease in double-strand break end resection. Mol Cell 2014, 54:1022-1023.
75. Unno J., Itaya A., Taoka M., Sato K., Tomida J., Sakai W., Sugasawa K., Ishiai M., Ikura T., Isobe T., et al. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair. Cell Rep 2014, 7:1039-1047.
76. Murina O., Aesch von C., Karakus U., Ferretti L.P., Bolck H.A., Hänggi K., Sartori A.A. FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. Cell Rep 2014, 7:1030-1038.
77. Staresincic L., Fagbemi A.F., Enzlin J.H., Gourdin A.M., Wijgers N., Dunand-Sauthier I., Giglia-Mari G., Clarkson S.G., Vermeulen W., Schärer O.D. Coordination of dual incision and repair synthesis in human nucleotide excision repair. EMBO J 2009, 28:1111-1120.
78. Kim H., Yang K., Dejsuphong D., D'Andrea A.D. Regulation of Rev1 by the Fanconi anemia core complex. Nat Struct Mol Biol 2012, 19:164-170.
79. Long D.T., Raschle M., Joukov V., Walter J.C. Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science 2011, 333:84-87.
80. Méchali M. Eukaryotic DNA replication origins: many choices for appropriate answers. Nat Rev Mol Cell Biol 2010, 11:728-738.
81. Zhang J., Dewar J.M., Budzowska M., Motnenko A., Cohn M.A., Walter J.C. DNA interstrand cross-link repair requires replication-fork convergence. Nat Struct Mol Biol 2015, 22:242-247.
82. Petermann E., Orta M.L., Issaeva N., Schultz N., Helleday T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell 2010, 37:492-502.
83. Toledo L.I., Altmeyer M., Rask M-B., Lukas C., Larsen D.H., Povlsen L.K., Bekker-Jensen S., Mailand N., Bartek J., Lukas J. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 2013, 155:1088-1103.
84. Siddiqui K., On K.F., Diffley J.F.X. Regulating DNA replication in eukarya. Cold Spring Harb Perspect Biol 2013, 5.
85. Huang J., Liu S., Bellani M.A., Thazhathveetil A.K., Ling C., de Winter J.P., Wang Y., Wang W., Seidman M.M. The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks. Mol Cell 2013, 52:1-13.
86. Yardimci H., Wang X., Loveland A.B., Tappin I., Rudner D.Z., Hurwitz J., van Oijen A.M., Walter J.C. Bypass of a protein barrier by a replicative DNA helicase. Nature 2012, 492:205-209.
87. Zhang J., Walter J.C. Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair 2014, 19:135-142.
88. Voulgaridou G-P., Anestopoulos I., Franco R., Panayiotidis M.I., Pappa A. DNA damage induced by endogenous aldehydes: current state of knowledge. Mutat Res/Fundamental Mol Mech Mutagenesis 2011, 711:13-27.
89. Mosammaparast N., Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 2010, 79:155-179.
90. Shen L., Song C-X., He C., Zhang Y. Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu Rev Biochem 2014, 83:585-614.
91. Luo W., Li H., Zhang Y., Ang C.Y. Determination of formaldehyde in blood plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 2001, 753:253-257.
92. 2O under controlled conditions. Am Ind Hyg Assoc J 1985, 46:1-3.
93. Chaw Y.F., Crane L.E., Lange P., Shapiro R. Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry 1980, 19:5525-5531.
94. Huang H., Hopkins P.B. DNA interstrand cross-linking by formaldehyde: nucleotide sequence preference and covalent structure of the predominant cross-link formed in synthetic oligonucleotides. J Am Chem Soc 1993, 115:9402-9408.
95. Brooks P.J., Zakhari S. Acetaldehyde and the genome: beyond nuclear DNA adducts and carcinogenesis. J Am Chem Soc 2003, 125:50-61.
96. Matsuda T., Kawanishi M., Yagi T., Matsui S., Takebe H. Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res 1998, 26:1769-1774.
97. Wang M., McIntee E.J., Cheng G., Shi Y., Villalta P.W., Hecht S.S. Identification of DNA adducts of acetaldehyde. Chem Res Toxicol 2000, 13:1149-1157.
98. Kozekov I.D., Nechev L.V., Moseley M.S., Harris C.M., Rizzo C.J., Stone M.P., Harris T.M. DNA interchain cross-links formed by acrolein and crotonaldehyde. J Am Chem Soc 2003, 125:50-61.
99. Wang H., Kozekov I.D., Harris T.M., Rizzo C.J. Site-specific synthesis and reactivity of oligonucleotides containing stereochemically defined 1,N2-deoxyguanosine adducts of the lipid peroxidation product trans-4-hydroxynonenal. J Am Chem Soc 2003, 125:5687-5700.
100. Summerfield F.W., Tappel A.L. Detection and measurement by high-performance liquid chromatography of malondialdehyde crosslinks in DNA. Anal Biochem 1984, 143:265-271.
101. Kozekov I.D., Nechev L.V., Sanchez A., Harris C.M., Lloyd R.S., Harris T.M. Interchain cross-linking of DNA mediated by the principal adduct of acrolein. Chem Res Toxicol 2001, 14:1482-1485.
102. Cho Y-J., Wang H., Kozekov I.D., Kurtz A.J., Jacob J., Voehler M., Smith J., Harris T.M., Lloyd R.S., Rizzo C.J., et al. Stereospecific formation of interstrand carbinolamine DNA cross-links by crotonaldehyde- and acetaldehyde-derived alpha-CH3-gamma-OH-1,N2-propano-2'-deoxyguanosine adducts in the 5'-CpG-3' sequence. Chem Res Toxicol 2006, 19:195-208.
103. Ridpath J.R., Nakamura A., Tano K., Luke A.M., Sonoda E., Arakawa H., Buerstedde J.M., Gillespie D.A.F., Sale J.E., Yamazoe M., et al. Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res 2007, 67:11117-11122.
104. Langevin F., Crossan G.P., Rosado I.V., Arends M.J., Patel K.J. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 2011, 475:53-58.
105. Garaycoechea J.I., Crossan G.P., Langevin F., Daly M., Arends M.J., Patel K.J. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 2012, 10.1038/nature11368.
106. Pontel L., Rosado I.V., Burgos-Barragan G., Garaycoechea J.I., Yu R., et al. Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen. Mol Cell 2015, in press.
107. Rosado I.V., Langevin F., Crossan G.P., Takata M., Patel K.J. Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat Struct Mol Biol 2011, 18:1432-1434.
108. Hira A., Yabe H., Yoshida K., Okuno Y., Shiraishi Y., Chiba K., Tanaka H., Miyano S., Nakamura J., Kojima S., et al. Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 2013, 122:3206-3209.
109. Oberbeck N., Langevin F., King G., de Wind N., Crossan G.P., Patel K.J. Maternal aldehyde elimination during pregnancy preserves the fetal genome. Mol Cell 2014, 55:807-817.
110. Garaycoechea J.I., Patel K.J. Why does the bone marrow fail in Fanconi anemia?. Blood 2014, 123:26-34.
111. Kurtz A.J. 1,N2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via schiff base linkage. J Biol Chem 2002, 278:5970-5976.
112. Tretyakova N.Y., Groehler A., Ji S. DNA-protein cross-links: formation, structural identities, and biological outcomes. Acc Chem Res 2015, 48:1631-1644.
113. Lu K., Ye W., Zhou L., Collins L.B., Chen X., Gold A., Ball L.M., Swenberg J.A. Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. J Am Chem Soc 2010, 132:3388-3399.
114. Loeber R., Michaelson E., Fang Q., Campbell C., Pegg A.E., Tretyakova N. Cross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustards. Chem Res Toxicol 2008, 21:787-795.
115. Loeber R.L., Michaelson-Richie E.D., Codreanu S.G., Liebler D.C., Campbell C.R., Tretyakova N.Y. Proteomic analysis of DNA-protein cross-linking by antitumor nitrogen mustards. Chem Res Toxicol 2009, 22:1151-1162.
116. Michaelson-Richie E.D., Loeber R.L., Codreanu S.G., Ming X., Liebler D.C., Campbell C., Tretyakova N.Y. DNA-protein cross-linking by 1,2,3,4-diepoxybutane. J Proteome Res 2010, 9:4356-4367.
117. Chvalova K., Brabec V., Kasparkova J. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res 2007, 35:1812-1821.
118. Duxin J.P., Dewar J.M., Yardimci H., Walter J.C. Repair of a DNA-protein crosslink by replication-coupled proteolysis. Cell 2014, 159:346-357.
119. Stingele J., Schwarz M.S., Bloemeke N., Wolf P.G., Jentsch S. A DNA-dependent protease involved in DNA-protein crosslink repair. Cell 2014, 158:327-338.
120. Nakano T., Morishita S., Katafuchi A., Matsubara M., Horikawa Y., Terato H., Salem A.M.H., Izumi S., Pack S.P., Makino K., et al. Nucleotide excision repair and homologous recombination systems commit differentially to the repair of DNA-protein crosslinks. Mol Cell 2007, 28:147-158.
121. Nakano T., Katafuchi A., Matsubara M., Terato H., Tsuboi T., Masuda T., Tatsumoto T., Pack S.P., Makino K., Croteau D.L., et al. Homologous recombination but not nucleotide excision repair plays a pivotal role in tolerance of DNA-protein cross-links in mammalian cells. J Biol Chem 2009, 284:27065-27076.
122. Reardon J.T., Sancar A. Repair of DNA-polypeptide crosslinks by human excision nuclease. Proc Natl Acad Sci U S A 2006, 103:4056-4061.
123. Baker D.J., Wuenschell G., Xia L., Termini J., Bates S.E., Riggs A.D., O'Connor T.R. Nucleotide excision repair eliminates unique DNA-protein cross-links from mammalian cells. J Biol Chem 2007, 282:22592-22604.
124. Mosbech A., Gibbs-Seymour I., Kagias K., Thorslund T., Beli P., Lou Povlsen Nielsen S.V., Smedegaard S., Sedgwick G., Lukas C., et al. DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks. Nat Struct Mol Biol 2012, 19:1084-1092.
125. Stingele J., Habermann B., Jentsch S. DNA-protein crosslink repair: proteases as DNA repair enzymes. Trends Biochem Sci 2014, 40:67-71.
126. Centore R.C., Yazinski S.A., Tse A., Zou L. Spartan/C1orf124, a reader of PCNA ubiquitylation and a regulator of UV-induced DNA damage response. Mol Cell 2012, 46:625-635.
127. Davis E.J., Lachaud C., Appleton P., MacArtney T.J., Thke I.N.A., Rouse J. DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. Nat Struct Mol Biol 2012, 19:1093-1100.
128. Peak J.G., Peak M.J., Sikorski R.S., Jones C.A. Induction of DNA-protein crosslinks in human cells by ultraviolet and visible radiations: action spectrum. Photochem Photobiol 1985, 41:295-302.
129. Banjar Z.M., Hnilica L.S., Briggs R.C., Stein J., Stein G. Crosslinking of chromosomal proteins to DNA in HeLa cells by UV gamma radiation and some antitumor drugs. Biochem Biophys Res Commun 1983, 114:767-773.
130. Lessel D., Vaz B., Halder S., Lockhart P.J., Marinovic-Terzic I., Lopez-Mosqueda J., Philipp M., Sim J.C.H., Smith K.R., Oehler J., et al. Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat Genet 2014, 46:1239-1244.
131. Maskey R.S., Kim M.S., Baker D.J., Childs B., Malureanu L.A., Jeganathan K.B., Machida Y., van Deursen J.M., Machida Y.J. Spartan deficiency causes genomic instability and progeroid phenotypes. Nat Commun 2014, 5:5744.
132. Garcia C.C.M., Angeli J.P.F., Freitas F.P., Gomes O.F., de Oliveira T.F., Loureiro A.P.M., Di Mascio P., Medeiros M.H.G. [13C2]-Acetaldehyde promotes unequivocal formation of 1,N2-propano-2'-deoxyguanosine in human cells. J Am Chem Soc 2011, 133:9140-9143.